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(57) ABSTRACT 
Various apparatuses, arrangements, and methods are pro-
vided for creating various structures including microstruc-
tures. In one embodiment, a method for creating a micro struc-
ture is provided comprising packing a plurality of particles 
into a micromold, and then applying energy to the particles in 
the micromold. As a result of the application of energy, a 
microstructure is formed in the micromold out of the par-
ticles. Thereafter, the microstructure is removed from the 
micromold. 
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PARTICLE BASED MOLDING 
CROSS REFERENCE TO RELATED CASES 
This application claims priority to co-pending Interna- 5 
tional Patent Application PCT/US2007 /067776 entitled "Par-
ticle Based Molding," filed on Apr. 30, 2007, which is incor-
porated herein by reference in its entirety, and which claims 
priority to U.S. Provisional Patent Application 60/796,419 
entitled "Methods and Devices for Delivery to Skin and Other 
10 
Applications," filed on May 1, 2006, which is also incorpo-
rated herein in its entirety. 
STATEMENT REGARDING FEDERALLY 
SPONSORED RESEARCH OR DEVELOPMENT 
2 
ment of the present invention. As shown, a micromold 100 is 
provided that includes cavities 103 that are filled with par-
ticles 106. Energy is applied to the micromold containing the 
particles 106, thereby resulting in the creation of the micro-
structures in themicromold 100.A detailed explanation of the 
various steps taken to create a microstructure as depicted in 
FIGS. lA through lF is provided below after a description of 
the structural components depicted. 
The micromold 100 may be constructed from various 
materials such as, for example, polymers including poly-di-
methyl-siloxane (PDMS) and poly(methyl methacrylate) 
(PMMA); metals, whether conventionally machined or elec-
troformed; ceramics, or other appropriate materials. The 
micromold 100 may be constructed, for example, by using a 
This invention was made with government support under 
contract number 8 ROI EB00260-03, awarded by the 
National Institutes of Health. The government has certain 
rights in the invention. 
15 process in which (i) a female master is created photolitho-
graphically out ofSU-8 epoxy photoresist, (ii) a male master 
is molded out of PDMS from the female master mold, and (iii) 
a female replicate mold is created out of PDMS from the male 
master structure. For further discussion of the creation of the 
BACKGROUND 
Conventional micromolding techniques use mJection 
molding concepts to fill micromolds with melted polymer 
materials. However, the conventional micromolding tech-
niques are limited in that they only use single-composition 
substances when creating microstructures. Also, microstruc-
tures having high aspect ratios and complex geometries are 
difficult to create using injection molding techniques because 
the high viscosity of polymer melt leads to premature cooling 
before the polymer completely fills the mold cavity. Also, the 
high temperatures and pressures of traditional processing can 
be detrimental to molding materials and prohibit the concept 
of multi-composition and multi-geometric structures. 
BRIEF DESCRIPTION OF THE DRAWINGS 
20 micromold 100, reference is made to Jung-Hwan Park, et al. 
"Polymer Particle-Based Micromolding to Fabricate Novel 
Microstructures," Biomed Microdevices, Vol. 9, pp. 223-234 
(2007), which is incorporated herein by reference. 
The particles 106 may comprise, for example, biodegrad-
25 able polymers such as poly-lactic acid (PLA), poly-glycolic 
acid (PGA), and their copolymers (PLGA). Such materials 
facilitate the creation of micro structures that may be used for 
medical applications as they safely degrade into biocompat-
ible monomers in the body and are approved by the Food and 
30 Drug Administration. This class of polymer microparticles 
has been studied extensively to encapsulate compounds such 
as drugs for sustained release for many applications, includ-
ing vaccine delivery, cancer treatment, hormone therapy, pro-
tein delivery, gene delivery, and diagnostic applications. For 
35 further discussion regarding the use of polymer micropar-
ticles to encapsulate various compounds set forth above, ref-
erence is made to the following published articles, each of 
these published articles being incorporated herein by refer-
ence: 
Many aspects of the invention can be better understood 
with reference to the following drawings. The components in 
the drawings are not necessarily to scale, emphasis instead 40 
being placed upon clearly illustrating the principles of the 
present invention. Moreover, in the drawings, like reference 
numerals designate corresponding parts throughout the sev-
eral views. 
H.J. Lee, G. Riley, 0. Johnson, J. L. Cleland, N. Kim, M. 
Charnis, L. Bailey, E. Duenas, A. Shahzamani, M. Mar-
ian, A. J. S. Jones, and S. D. Putney, "In vivo character-
ization of sustained-release formulations of human 
growth hormone," J. Pharmacol. Exp. Ther. 281, 1431-
1439 (1997a). FIGS. lA through lF are drawings that illustrate the ere- 45 
ation of various structures according to various embodiments 
of the present invention; 
FIGS. 2A through 2F are drawings that illustrate the cre-
ation of further structures according to various embodiments 
of the present invention; 
FIGS. 3A through 3D are drawings that illustrate the cre-
ation of composite structures according to an embodiment of 
the present invention; 
50 
FIG. 4 is a picture of particles employed to create the 
structures described in FIGS. lA through 3D according to an 55 
embodiment of the present invention; 
FIG. 5 is a picture of an example of a structure created as 
illustrated in FIGS. lA through lF according to an embodi-
ment of the present invention; and 
FIG. 6 is a picture that shows a portion of the structure of 60 
FIG. 5 according to an embodiment of the present invention. 
DETAILED DESCRIPTION OF THE PREFERRED 
EMBODIMENT 
Referring to FIGS. lA through lF, shown is a method by 
which a microstructure is created according to an embodi-
65 
H.K. Lee, J. H. Park, and K. C. Kwon, "Double-walled 
microparticles for single shot vaccine," J. Control. Rel. 
44, 283-293 (1997b ). 
D. T. Birnbaum, and L. Brannon-Peppas, Microparticle 
drug delivery systems. in Cancer Drug Discovery and 
Development, edited by D. M. Brown (Human Press, 
Totowa, N.J., 2003) pp.117-135. 
D. Jain, A. K. Panda, andD. K. Majumdar, Eudragit, "SlOO 
entrapped insulin micro spheres for oral delivery," AAPS 
PharmSciTech. 6, E100-E107 (2005). 
S. R. Little, D. M. Lynn, Q. Ge, D. G. Anderson, S. V. 
Puram, J. Chen, H. N. Eisen, and R. Langer, "Poly-B 
amino ester-containing microparticles enhance the 
activity of nonviral genetic vaccines," Proc. Natl. Acad. 
Sci. (USA) 101, 9534-9539 (2004). 
S. J. Lee, J. R. Jeong, S. C. Shin, J.C. Kim,Y. H. Chang, K. 
H. Lee, and J. D. Kim, "Magnetic enhancement of iron 
oxide nanoparticles encapsulated with poly(D,L-lac-
tide-co-glycolide ),"Coll. Surf. A 255, 19-25 (2005). 
Such particles are typically prepared using an oil-water, 
double-emulsion system; spray drying methods; supercritical 
conditioning methods; and milling methods. For further 
US 8,101,114 B2 
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The particles 106 may comprise microparticles when they 
are used to fill a micromold and are thus appropriately sized to 
fit in the cavities 103. Also, the particles 106 may comprise 
different sizes and shapes. 
Referring once again to FIGS. lA through lF, next a 
method is described for creating a microstructure according 
to an embodiment of the invention. First, as depicted in FIG. 
lA, the micromold 100 is covered with particles 106. As 
illustrated in FIG. lB, a male master structure 109 is used to 
information on the creation of particles 106, see Jung-Hwan 
Park, et al. "Polymer Particle-Based Micromolding to Fabri-
cate Novel Microstructures," Biomed Microdevices, Vol. 9, 
pp. 223-234 (2007) which is incorporated by reference above. 
Also, see J. Benoit, H. Marchais, H. Rolland, and V. V. Velde, 
Biodegradable microspheres: Advances in production tech-
nology. in Microencapsulaton: Methods and Industrial Appli-
cation, edited by S. Benita (Marcel Dekker, New York, 1996) 
pp. 35-72; and J. H. Park, M. G. Allen, and M. R. Prausnitz, 
"Polymer microneedles for controlled-release drug delivery," 
Pharm. Res. Vol. 23, pgs. 1008-1019, (2006), such articles 
being incorporated herein by reference. 
In addition, the particles 106 may comprise other materials 
such as, for example, poly(methylmethacrylate), polyethyl-
ene, polypropylene, or other polymers; metals; ceramics; or 
polymer or polymer-coated particles, or other appropriate 
materials. 
10 then push the particles 106 into the cavities 103 of the micro-
mold 100. These steps are repeated until the cavities 103 are 
substantially full as depicted in FIG. lC. In this manner, 
particles 106 are placed in the cavities 103 of the micromold 
100. Alternatively, the particles 106 may be placed in the 
15 micromold 100 in some other manner. Also as shown, in some 
embodiments, a particle cake 113 is left on the exit side of the 
micromold 100. 
A wide range of drugs may be included or encapsulated in 
the microstructures and methods. As used herein, the term 20 
"drug" is used broadly to refer to any prophylactic, therapeu-
tic, or diagnostic agent, or other substance that may be suit-
able for inclusion in or on a micro structure or other structure, 
including pharmaceutical excipients and substances for tat-
tooing, cosmetics, and the like. A drug can be a substance 25 
having biological activity. A drug formulation may include 
various forms, such as liquids, liquid solutions, gels, solid 
particles (e.g., microparticles, nanoparticles ), or combina-
tions thereof. 
Next, as depicted in FIG. lD, a base substrate such as a 
PDMS sheet 116 (or sheet of other appropriate material) is 
placed onto the particle cake 113. Alternatively, the particle 
cake on the exit side of the micromold 100 may serve as a base 
substrate without the sheet 116. As an additional alternative, 
any appropriate structure may be used as the base substrate 
provided that can adhere to the structures formed in the cavi-
ties 103. Thus, as contemplated herein, the concept of a base 
substrate refers to any structure to which the structures cre-
ated in the cavities of a mold (or micromold) can adhere as can 
be appreciated. Thereafter, in FIG. lE, energy or a chemical 
treatment is applied to the micromold 100 in order to form a 
30 microstructure 119 in the micromold 100. A drug may comprise small molecules, large (i.e., macro-) 
molecules, or a combination thereof. In representative, non-
limiting, embodiments, the drug can be selected from among 
amino acids, vaccines, antiviral agents, DNA/RNA, gene 
delivery vectors, interleukin inhibitors, immunomodulators, 
35 
neurotropic factors, neuroprotective agents, antineoplastic 
agents, chemotherapeutic agents, polysaccharides, anti-co-
agulants, antibiotics, analgesic agents, anesthetics, antihista-
mines, anti-inflammatory agents, and vitamins. A drug may 
be selected from suitable proteins, peptides and fragments 40 
thereof, which can be naturally occurring, synthesized or 
recombinantly produced. 
A variety of other pharmaceutical agents known in the art 
may be formulated for administration via the micro structures 
such as microneedles or other structures as described herein. 45 
Examples include beta-adrenoceptor antagonists (e.g., car-
teolol, cetamolol, betaxolol, levobunolol, metipranolol, 
timolol), miotics (e.g., pilocarpine, carbachol, physostig-
mine ), sympathomimetics (e.g., adrenaline, dipivefrine ), car-
bonic anhydrase inhibitors (e.g., acetazolamide, dorzola- 50 
mide), prostaglandins, anti-microbial compounds, including 
anti-bacterials and anti-fungals (e.g., chloramphenicol, chlo-
rtetracycline, ciprofloxacin, framycetin, fusidic acid, gen-
tamicin, neomycin, norfloxacin, ofloxacin, polymyxin, pro-
pamidine, tetracycline, tobramycin, quinolines), anti-viral 55 
compounds (e.g., acyclovir, cidofovir, idoxuridine, interfer-
ons), aldose reductase inhibitors, anti-inflammatory and/or 
anti-allergy compounds (e.g., steroidal compounds such as 
betamethasone, clobetasone, dexamethasone, fluo-
rometholone, hydrocortisone, prednisolone and non-steroi- 60 
dal compounds such as antazoline, bromfenac, diclofenac, 
indomethacin, lodoxamide, saprofen, sodium cromoglycate ), 
local anesthetics (e.g., amethocaine, lignocaine, oxbup-
rocaine, proxymetacaine ), cyclosporine, diclofenac, urogas-
trone and growth factors such as epidermal growth factor, 65 
mydriatics and cycloplegics, mitomycin C, and collagenase 
inhibitors. 
In one embodiment, the energy that is applied to the par-
ticles 106 is ultrasonic energy that causes adjacent ones of the 
particles 106 to be attached to each other.As depicted in FIG. 
lD, a sonically reflective structure 121 may be placed under 
the micromold 100 opposite the exit side of the mold during 
the application of the ultrasonic energy to reflect sound waves 
back into the mold. The ultrasonic energy may be applied to 
the micromold 100, for example, by applying an ultrasonic 
horn 123 to the micromold 100 or to the PDMS sheet 116 as 
illustrated in FIG. lE.Alternatively, ultrasonic energy may be 
applied using other well-known techniques such as, for 
example, immersion in an ultrasonically-excited water bath. 
The application ofultrasonic energy to the micromold 100, 
whether it is directly to the micromold 100 or through the 
PDMS sheet 116, causes the local welding of adjacent par-
ticles 106 to each other. Local welding of adjacent particles 
106 refers to the fact that the immediate surfaces of the 
particles 106 where particles 106 are in contact are altered so 
as to be attached to each other. For example, it is theorized that 
the movement of particles 106 next to each other due to the 
application of ultrasonic energy results in friction and heating 
of the particles 106 at the points of friction. Such heating 
results in local welding of the particles. It may be possible that 
the local welding results from other phenomena beyond heat-
ing. 
Once the ultrasonic energy has been added such that the 
desired local welding of the particles 106 has been accom-
plished, then the resulting microstructure 119 as depicted in 
FIG. lF may be extracted from the micromold 100. 
It should also be noted that it is possible that a mold other 
than a micromold 100 may be employed. Although there is no 
hard and fast rule as to when a mold is a micromold as 
opposed to a larger mold that is not classifiable as "micro," 
generally it can be asserted that molds that are "micromolds" 
are those that can be used to create structures having some 
physical dimension or feature that is less than or equal to 1 
millimeter in size. It may be the case, for example, that a 
US 8,101,114 B2 
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micromold 100 may be employed to create microstructures 
that are generally less than 1 millimeter in size, and yet are 
attached to a substrate that is much larger than 1 millimeter. 
As depicted in FI GS. lA-F and 2A-F, the structures shown 
therein comprise, for example, microstructures that are actu-
ally microneedles that may be inserted into biological tissue. 
Although microneedles are shown, it is understood that any 
other type of microstructure may be created using the prin-
ciples described herein, where the microneedles are shown 
merely as an example. Also, it is understood that structures 
other than microstructures may be created using the prin-
ciples discussed herein. Such structures may comprise, for 
example, stents, microfluidic networks, and neural interfaces. 
The application of ultrasonic energy to the particles 106 in 
the micromold 100 or other mold provides various advan-
tages. Among these advantages is the fact that the resulting 
microstructure 119 or other structure is porous in nature given 
that the particles 106 are not fully melted, thereby allowing 
substances to flow into and out of, or through the resulting 
microstructure 119 or other structure. 
Thus, the microstructure 119 or other structure may be 
constructed so as to be porous in nature for specific applica-
tion where such porosity is desired. For example, where in 
one application, a mold may be created for a stent that is used 
to expand arterial walls, etc. The porous nature of a structure 
created using ultrasonic energy as described above may be 
useful to allow tissue to grow and enmesh the stent or other 
device. The degree of porosity of the resulting structure may 
be determined in part based upon the size( s) of the particles 
106 placed in the micromold 100 or other mold. 
In addition, the local welding of particles 106 by the appli-
cation of ultrasonic energy facilitates the creation of the 
microstructure 119 or other structure without unduly raising 
the temperature of an interior portion of the particles 106 
themselves. To this end, local welding can be achieved with-
out raising the temperature of the interior portion of the par-
ticles above a predefined threshold. Thus, the temperature in 
the interior portion of the particles 106 can be maintained at 
less than the predefined threshold during the local welding. 
This is advantageous where the particle 106 is composed of a 
substance that degrades at temperatures above the predefined 
threshold. 
For example, the particles 106 may be made out of various 
biodegradable materials and may include various drugs or 
other substances that would be degraded or damaged if 
exposed to excessive heat. The local welding of particles 106 
accomplished by way of ultrasonic welding prevents 
unwanted heating of the interior of the particles 106, thereby 
preventing unwanted degradation of substances such as drugs 
or other compounds that are to be released when the structure 
6 
the structures maybe porous if the heat is applied in a short 
interval such as is the case with a partial melting of the 
particles 106. 
In addition, it may be possible to apply energy to a mold in 
some other manner, such as exposure of a mold to an open 
flame, by use of induction or resistive (ohmic) heating, by 
mechanical vibration, or other approaches. 
In addition, one or more chemicals can be applied to a 
micromold 100 to attach particles 106 within the micromold 
10 100 to each other. Stated another way, the micromold 100 
may undergo a chemical treatment. The resulting structure 
can have porosity or can have little or no porosity. In one 
embodiment, a chemical can be a solvent that dissolves one or 
more of the materials comprising the particles 106. This 
15 chemical can be provided as a liquid or as a vapor. A brief 
exposure of the micromold 100 to the chemical can dissolve 
or partially dissolve the outer portion of one or more particles 
106, but have insufficient time to penetrate into the interior of 
the one or more particles 106. This would achieve a local 
20 welding of the particles 106 to each other. In one embodi-
ment, this method could protect drugs encapsulated within 
particles 106 from exposure to the solvent, and thereby pre-
vent solvent-based damage to the drug. 
The brief exposure to the chemical could be achieved by 
25 adding liquid chemical into the micromold 100 and then 
removing the chemical by pouring it out, or by vaporizing it 
by increasing the temperature, lowering the pressure or other 
methods. The brief exposure to the chemical could also be 
achieved by adding a chemical vapor to the micromold 100 
30 and then removing the chemical vapor by aerating the micro-
mold 100, evacuating the micromold 100 or otherwise dis-
placing the chemical vapor with another gas or vapor. A 
longer exposure to a chemical could similarly be achieved by 
leaving the chemical in the micromold 100 for a longer period 
35 oftime. 
Local welding of particles 106 to each other within the 
micromold 100 could also be achieved by altering the chemi-
cal environment in other ways. For example, the pH, ionic 
composition, ionic strength, viscosity, thermal conductivity, 
40 electrical conductivity, and other properties of the environ-
ment in the micromold 100 could be altered. In one embodi-
ment, the surface properties of particles 106 could be such 
that they do not adhere to each other at a first pH, but do 
adhere to each other at a second pH, perhaps due to changes 
45 in the charge state of molecules located on the particle sur-
face. In this way, particles 106 could be placed within a 
micromold 100 at the first pH and then adhered to each other 
within the micromold 100 by switching to the second pH. 
Attachment of particles 106 to each other could also be 
50 achieved by stimulating a chemical reaction within the micro-
mold 100. The chemical reaction could be stimulated actively 
by applying energy to the micromold 100, by altering the 
chemical environment in the micromold 100 or other meth-
is inserted into a patient, etc. It is possible that heating that 
might occur at the sites of the local welds between particles 
106 that might do damage to substances such as drugs and or 
other substances encapsulated in the particles 106. However, 
since the local welding is, in fact, localized to the sites where 55 
particles 106 are attached, the majority of the substances 
encapsulated in the particles 106 are left intact. 
ods. The chemical reaction could occur spontaneously upon 
placement of the particles 106 within the micromold 100, 
possibly after a time delay. In one embodiment, molecules on 
the surfaces of the particles 106 react with each other to form 
chemical bonds that attach the particles 106. In one embodi-
ment, the reaction could be a polymerization reaction or a 
cross-linking reaction and could involving stimulation using 
ultraviolet light. 
Alternatively, energy may be applied to the particles 106 by 
applying heat to the micromold 100 by placing the micromold 
100 in an oven or via some other approach. Where the micro- 60 
mold 100 or other type of mold is placed in an oven, the 
resulting heat transferred to the particles causes the particles 
to melt either partially or completely. To the extent that par-
ticles 106 are mostly or completely melted, the microstruc-
ture 119 or other structure resulting therefrom may conform 65 
more completely to the shape of the mold. Such structures 
may have little or no porosity as can be appreciated. However, 
With reference then to FIGS. 2A though 2F, shown are 
steps of a method for creating a micro structure according to 
an embodiment of the invention. As shown in FIG. 2A, par-
ticles 206a are filled into the cavities 203 of a micromold or 
other mold (hereafter mold 200) in a manner similar to that 
described with reference to FIG. lA. The particles 206a may 
US 8,101,114 B2 
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be the same as the particles 106 described above. Note that the 
cavities 203 of the mold 200 may be fully or partially filled 
with particles 206a. In order to ensure that no particle cake is 
left on the top of the mold 200, adhesive tape may be pressed 
up against the top of the mold 200 to remove excess particles 5 
200 from the mold 200. 
8 
The particles 206a and 206b may be comprised of different 
compositions. For example, such different compositions may 
comprise the inclusion or encapsulation of different sub-
stances in the different particles 206a and 206b. Such differ-
ent substances may comprise, for example, different drugs in 
the case where the structures created are to be inserted into 
biological tissue for the timed release of drugs, etc. 
Next, in FIG. 2E, a base substrate 219 is formed by apply-
ing energy or chemical treatment to a particle cake placed at 
Next, energy or a chemical treatment as described above is 
applied to the mold 200 to transform the particles 206a into 
structures 209a that conform with the cavities 203 of the 
mold. To apply energy to the mold 200, for example, the mold 
200 may be placed in an oven and heated so that the particles 
206a in the cavities 203 are at least partially melted and 
conform with the cavities 203 of the mold 200. Alternatively, 
ultrasonic energy may be applied to the mold 200 in a manner 
described above with respect to FIG. lE. Where the particles 
206a are substantially melted due to the application of energy 
in the form of heat, the resulting structures 209a formed in the 
cavities 203 are non-porous. Alternatively, where ultrasonic 
energy is applied, the structures 209a may be porous in 
10 the exit side of the mold 200. Alternatively, the base substrate 
219 may comprise a sheet of material placed over the mold 
200 and attaching the sheet of material to the structures 209b 
via the application of a chemical treatment or by the applica-
tion of energy by way of heating, ultrasonic welding, or via 
15 some other energy source. As an additional alternative, any 
structure may be used as a base substrate provided that you 
can adhere the structures 209b to such structure. After the 
application of energy or chemical treatment to the mold 200 
for the last time, the resulting structure 223 is extracted from 
20 the mold 200. 
nature. By virtue of the fact that the structure 223 is formed from 
Also, where the particles 206a are substantially melted, the particles 206 of multiple different compositions, the compo-
cavities 203 may ultimately be partially filled as the volume sition of the structure 223 is described herein as non-homog-
ofthe cavities 203 filled by the melted particles 206a is less enous. As contemplated herein, the term non-homogenous 
than the volume filled by the particles 206a themselves due to 25 refers to structures that differ in composition such as combi-
the fact that voids between particles 206a are at least partially nations of different polymers or combinations of polymers 
or entirely eliminated. As depicted in FIG. 2B, the particles with different materials, or combinations of polymers with 
206a have been exposed to the needed amount of energy or portions without material such as voids. Depending upon the 
the proper type of chemical treatment in order to melt or form of energy or the chemical treatment applied to the mold 
otherwise adhere the particles 206a together into nonporous 30 200, the resulting structure 223 may also be porous or non-
structures 209a in the cavities 203. Note that the cavities 203 porous as described above. Also, the structure 223 may be a 
are thus partially filled. microstructure where the mold 200 is a micromold. 
Next, as depicted in FIG. 2C, a second group of particles With reference to FI GS. 3A through 3 D, shown are various 
206b is placed in the free volume of the cavities 203 after the steps of a method of creating a composite structure 300 
particles 206a have been reduced by the application of 35 according to an embodiment of the present invention. The 
energy. According to one embodiment, the particles 206b composite structure 300 may comprise, for example, a reen-
have a lower melting point than the particles 206a so that trant structure. Also, the composite structure 300 may be, for 
energy may be applied to melt the particles 206b without example, a composite microstructure or other structure. A 
melting the structures 209a resulting from the reduction of composite structure 300 comprises a single new structure that 
the particles 206a. Alternatively, the particles 206b may react 40 is created from two structures that are attached or otherwise 
to a different chemical treatment from that which was applied 
to the particles 206a. As depicted in FIG. 2D, structures 209b 
are created that include a first layer 213 from the material of 
the particles 206a and a second layer 216 from the material of 
the particles 206b. The lower melting point of the particles 45 
206b means that the second layer 216 can be added by melting 
the particles 206b without melting the first layer 213. Alter-
natively, the susceptibility of the particles 206b to a different 
chemical treatment than the particles 206a forming the first 
layer 213 means that the particles 206b can be chemically 50 
treated without affecting the first layer 213. 
Alternatively, were ultrasonic energy is applied, there may 
not be much reduction due to the filling of voids between 
particles 206a or 206b, where a porous structure results. 
According to one embodiment, several layers 213, 216 55 
may be created in a given cavity 203 of a mold 200. The 
volume of each of the layers 213, 216 can be determined 
based upon the volume of particles 206 of a given size added 
that can be reduced to a single volume due to the addition of 
energy to the mold 200. Although only 2 layers are shown, it 60 
is understood that many different layers can be created in this 
manner. 
put together. A reentrant structure is "reentrant" in the sense 
that it involves inserting or "reentering" a first structure into a 
mold in order such that a second structure created in the mold 
during the reentry by the first structure adheres to and 
becomes part of a common composite structure 300. 
Turning to FIG. 3A, shown is a mold 303 with cavities 306 
that have been filled with particles 309. The cavities 306 are 
not filled entirely with the particles 309 in order to allow room 
for the insertion of a first structure as will be described. 
As depicted in FIG. 3B, a first structure 313 is positioned 
over the mold 303 and at least one portion of the first structure 
313 is inserted into a cavity 306 of the mold 303 with the 
particles 309. As shown, the first structure 313 includes a 
number of needle-like structures 316 that extend from a base 
substrate. Alternatively, the first structure 313 may comprise 
a single needle-like structure 316. 
Once the first structure 313 is partially inserted or "reen-
tered," for example, into the cavities 306, then energy or a 
chemical treatment is applied to the particles 309 in the cavi-
ties 306 of the mold 303. The energy applied may be in the 
form ofheat, for example, where the mold 303 is placed in an 
oven. As depicted in FIG. 3C, according to one embodiment, 
the particles 309 in each of the cavities 306 are at least 
partially melted into a plurality of second structures 319, each 
In another embodiment, the particles 206a and 206b may 
be mixed before being placed in the cavities 203 of the mold. 
Thereafter, energy or chemical treatment may be applied to 
cause either local welding or melting of the particles as dis-
cussed above. 
65 second structure 319 adhering to a respective needle-like 
structure 316 of the first structure 131. In yet another embodi-
ment, a chemical treatment may be applied that results in the 
US 8,101,114 B2 
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creation of the second structures 319 and the adherence of 
second structures 319 to the first structure 131 in a similar 
manner. 
10 
Referring next to FIG. 4, shown is an image of particles 401 
that may be used as the particles 106, 206a, 206b, 306 accord-
ing to the various embodiments of the present invention. The 
particles 401 were created using a spray-drying technique, 
although other standard powder formation techniques could 
be used. The particles 401 generally are measured to be 
approximately 25 µm or less. 
With reference to FIG. 5, shown is an image of an actual 
microstructure 501 that was formed by the application of 
As depicted in FIG. 3C, the volume of the particles 309 in 
the cavities 306 is reduced due to the melting or chemical 
alteration of the particles 309 and the filling of voids between 
the particles 309. The first and second structures 313/316 
form the composite structure 300. The composite structure 
300 is removed from the mold 303 as shown in FIG. 3D. 
Alternatively, the structure 300 may be considered to include 
multiple "arrowhead-like" composite structures 300a that are 
mounted on a base substrate. 
According to one embodiment, the same mold 303 is 
advantageously used to create the first structure 313 and the 
second structures 319. In order to create the first structure 
313, the particles 309 are placed in the cavities 306 of the 
mold 303 and the first structure is created as set forth above 
with a base substrate such as a particle cake, a sheet of 
material or other structure as described above with reference 
10 ultrasonic energy as described above according to various 
embodiments of the present invention. The image of FIG. 6 
shows a closeup view of a portion of the micro structure 501 in 
which it is seen that adjacent particles are locally welded 
together by the application of ultrasonic energy according to 
15 various embodiments of the present invention. 
It should be emphasized that the above-described embodi-
ments of the present invention, are merely possible examples 
of implementations set forth for a clear understanding of the 
various embodiments of the invention. Many variations and 
to FIGS. lA through 2F. Alternatively, two different molds 
303 may be employed to create the composite structure(s) 
300/300a. Specifically, where two different molds are 
employed, a portion of the first structure would reenter a 
second mold so that second structures that differ can adhere 
thereto to form the ultimate composite structure. 
20 modifications may be made to the above-described embodi-
ment(s) of the invention without departing substantially from 
the spirit and principles of the invention. All such modifica-
tions and variations are intended to be included herein within 
the scope of this disclosure and the various embodiments of 
25 the present invention and protected by the following claims. 
According to one embodiment, a melting point of the first 
structure 313 is higher than the melting point of the particles 
309 from which the second structures 319 are formed. Thus, 
assuming that the assembly represented by the structure 313 
reentered into the mold 303 as depicted in FIG. 3C, is placed 30 
in an oven set at a temperature that is between the melting 
points of the first structure 313 and the particles 309, the first 
structure 313 will not melt while the particles 309 melt to 
form the second structure( s) 319. Alternatively, application of 
ultrasonic energy to the mold 303 may not cause much to 35 
change in the first structure 313 while causing the particles 
309 to adhere to each other and to the first structure 313. 
Also, the first structure 313 may be subject to a first chemi-
cal treatment and the particles 309 may be subject to a second 
chemical treatment that differs from the first chemical treat- 40 
ment. As such, the application of the second chemical treat-
ment to the particles 309 will not cause the first structure 313 
to be adversely affected. In still another embodiment, the 
same chemical treatment may be applied to both the first 
structure 313 and the particles 309 with such a time duration 45 
or concentration, or in some other manner, etc., that the par-
ticles 309 form a second structure adhered to the first structure 
313 without unacceptably affecting the first structure 313. 
In addition, the first structure 313, the needle-like struc-
tures 316, the second structures 319, and the composite struc- 50 
tures 300/300a may all be microstructures as described 
above. 
In one embodiment, the approach described with reference 
to FIGS. 3A through 3D advantageously provide a way to 
create a structure that might normally require a mold to be 55 
taken apart in pieces to facilitate extraction. This approach is 
especially useful on a micro-scale in which molds comprising 
two or more pieces to create a mold cavity do not exist. 
The invention claimed is: 
1. A method, comprising the steps of: 
placing a plurality of first polymeric particles into a micro-
mold; 
placing a plurality of second polymeric particles into the 
micromold, the second polymeric particles coming into 
contact with the first polymeric particles; 
applying ultrasonic energy to the first and second poly-
meric particles in the micromold, thereby forming a first 
microstructure and a second microstructure, respec-
tively in the micromold out of the particles, wherein the 
energy causes the first microstructure to adhere to the 
second microstructure, thereby forming a composite 
microstructure; and 
removing the composite microstructure from the micro-
mold. 
2. The method of claim 1, further comprising the step of 
placing a base substrate at an exit side of the micromold, 
where the ultrasonic energy is applied to the base substrate. 
3. The method of claim 1, wherein a physical dimension of 
the first microstructure is less than 1 millimeter. 
4. The method of claim 1, further comprising the step of 
placing a sonically reflective structure under the micromold 
opposite the exit side of the micromold during the application 
of the ultrasonic energy to the micromold. 
5. The method of claim 1, wherein a drug is included in at 
least one of the first and second polymeric particles. 
6. The method of claim 1, wherein a melting point of the 
second polymeric particles are higher than the melting point 
of the first polymeric particles. 
* * * * * 
